Pomdoctor Limited (POM)

Pomdoctor Statistics

Total Valuation

Pomdoctor has a market cap or net worth of $640.77 million. The enterprise value is $700.16 million.

Market Cap	640.77M
Enterprise Value	700.16M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Pomdoctor has 118.44 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	118.44M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+112.23%
Owned by Insiders (%)	21.83%
Owned by Institutions (%)	n/a
Float	46.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.36
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	14.92
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.21

Current Ratio	0.21
Quick Ratio	0.09
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.82

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-26.16%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	17.72%
Revenue Per Employee	$300,843
Profits Per Employee	-$125,903
Employee Count	156
Asset Turnover	6.09
Inventory Turnover	26.98

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	72.62
Average Volume (20 Days)	3,278,274

Short Selling Information

The latest short interest is 120,063, so 0.10% of the outstanding shares have been sold short.

Short Interest	120,063
Short Previous Month	n/a
Short % of Shares Out	0.10%
Short % of Float	0.26%
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pomdoctor had revenue of $46.93 million and -$19.64 million in losses. Loss per share was -$0.52.

Revenue	46.93M
Gross Profit	6.53M
Operating Income	-3.23M
Pretax Income	-19.64M
Net Income	-19.64M
EBITDA	-3.21M
EBIT	-3.23M
Loss Per Share	-$0.52

Balance Sheet

The company has $1.05 million in cash and $60.43 million in debt, giving a net cash position of -$59.38 million or -$0.50 per share.

Cash & Cash Equivalents	1.05M
Total Debt	60.43M
Net Cash	-59.38M
Net Cash Per Share	-$0.50
Equity (Book Value)	-68.46M
Book Value Per Share	-8.19
Working Capital	-19.41M

Cash Flow

In the last 12 months, operating cash flow was -$2.21 million and capital expenditures -$5,175, giving a free cash flow of -$2.27 million.

Operating Cash Flow	-2.21M
Capital Expenditures	-5,175
Free Cash Flow	-2.27M
FCF Per Share	-$0.02

Margins

Gross margin is 13.92%, with operating and profit margins of -6.88% and -41.85%.

Gross Margin	13.92%
Operating Margin	-6.88%
Pretax Margin	-41.84%
Profit Margin	-41.85%
EBITDA Margin	-6.84%
EBIT Margin	-6.88%
FCF Margin	n/a

Dividends & Yields

Pomdoctor does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-3.07%
FCF Yield	-0.35%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pomdoctor has an Altman Z-Score of -66.5 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-66.5
Piotroski F-Score	3